StonvexLoading…
StonvexStonvexStonvexCore line items from INGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $13.96B | $52.56B | $37.68B | $25.07B |
Operating Income | $222.91M | $876.93M | $567.19M | $343.68M |
Net Income | $98.87M | $327.88M | $206.47M | $107.02M |
EPS (Diluted) | $0.42 | $1.39 | $0.88 | $0.46 |
Total Assets | $20.95B | $21.24B | $19.22B | $19.45B |
Total Liabilities | $16.74B | $17.00B | $15.12B | $15.41B |
Cash & Equivalents | $915.99M | $1.86B | $802.63M | $856.67M |
Free Cash Flow OCF − CapEx | $-1.01B | $785.37M | $-738.36M | $-563.35M |
Shares Outstanding | 235.16M | 235.07M | 234.84M | 234.84M |